Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

OurCrowd & NOAH Advisors Partner to Jointly Promote Startup Investments in Europe

Published

on

Reading Time: 4 minutes

Israel’s most active venture investor partners with Europe’s leading
Internet-focused corporate finance boutique

JERUSALEM & LUCERNE, Switzerland–(BUSINESS WIRE)–OurCrowd,
a leading global investment platform and Israel’s most active venture
investor, has announced a new strategic relationship with NOAH
Advisors
, a leading European corporate finance boutique and
organizer of the NOAH Conferences. NOAH Advisors will support OurCrowd
in expanding its European deal flow into top European startups, in
countries such as Germany, Switzerland, and the UK. As part of the
partnership, NOAH Advisors’ network of Family Offices, senior
executives, tech investors, and startups will gain access to OurCrowd’s
top investment opportunities. NOAH Advisors and selected clients will
gain ‘VIP’ access to OurCrowd’s annual Global Investment Summit
(February 11th – 13th, 2020) in Jerusalem.

This partnership will launch at the NOAH Conference in Berlin (June 13th
– 14th, 2019), which will feature selected OurCrowd portfolio
companies, the principals of which will have the opportunity to showcase
and expand business development relationships in Europe. OurCrowd
Management will be speaking at NOAH Berlin, NOAH London (October 30th
– 31st, 2019), and the newly announced NOAH Zurich (September
22nd – 23rd, 2020), which will be followed by the
first Family Office Day (September 24th), co-hosted with the
Family Office Circle (FOC). The Zurich conference is an invite-only
event designed to connect international investors and Family Offices
with Swiss startups and global success stories.

OurCrowd CEO Jon Medved said, “Europe is practically next door, with
many Israeli startups choosing to focus on this market. We are excited
to partner with NOAH in growing OurCrowd’s European activity both in
terms of high-quality investors and impressive deal flow. There are
amazing innovations being developed in Europe now, and now is the time
to bring Israel and Europe closer, collaborating on new ideas and
innovation finance.”

NOAH Advisors founder and CEO Marco Rodzynek said, ”The partnership with
OurCrowd allows NOAH to offer fantastic new investment products to our
network. Family Offices and high net-worth individuals, who are
increasingly interested in growth investments, get directly exposed to
the best companies in Israel and globally. Moreover, OurCrowd opens up a
new pool of capital to the best European growth companies.”

About OurCrowd: OurCrowd is the leading global equity
crowdfunding platform for accredited investors. Managed by a team of
seasoned investment professionals and led by serial entrepreneur Jon
Medved, OurCrowd vets and selects companies, invests its own capital,
and invites its accredited membership of investors and institutional
partners to invest alongside in these opportunities. OurCrowd provides
support to its portfolio companies, assigns industry experts as mentors,
and creates growth opportunities through its network of strategic
multinational partnerships. The OurCrowd community consists of almost
30,000 registered investors from over 180 countries. Rated “the most
active venture investor in Israel” by Pitchbook, OurCrowd has $1B in
commitments and has made investments in 170 companies and 18 funds.
OurCrowd already has 34 exits to date. OurCrowd exits include: Beyond
Meat (NASDAQ: BYND), Jump Bikes (sold to Uber, NYSE: UBER), Magisto
(sold to Vimeo), Briefcam (sold to Canon), Argus (sold to Continental),
Crosswise (sold to Oracle) and Replay (sold to Intel). To join OurCrowd
as an accredited investor, visit ourcrowd.com.

About OurCrowd Events:

OurCrowd’s annual Global Investor Summit is Israel’s most important
event in the tech ecosystem and is attended by thousands of investors
from around the world, hundreds of multinationals, and entrepreneurs.
Held at the International Convention Center in Jerusalem, the 2019 event
boasted 18,000 registrations from over 180 countries across the world,
including tech entrepreneurs, government officials, and representatives
from some 400 multinationals. The Summit anchors a week of events and
activities in Israel that provide a unique insider’s look at the
innovation ecosystem, including tech events, workshops, VC forums, CEO
interchanges, press tours, and legendary parties. To apply for a ticket
to the 2020 OurCrowd Summit, visit http://summit.ourcrowd.com/apply-for-summit-2020.

About NOAH Advisors: NOAH Advisors is a leading pan-European
corporate finance boutique focused on mature digital and fast-growing
companies. The team advises on carefully selected M&A transactions and
major capital raisings starting at €50million. NOAH combines bulge
bracket investment banking skills (its partners came out of Lehman
Brothers London), an unparalleled access to strategic and financial
investors around the globe and unique Internet industry insight. NOAH is
independent and provides honest and unbiased advice. Since its
foundation 2009, NOAH has completed 25 transactions, including an
undisclosed investment in 10Bis from TA Associates in May 2016, the
$800m sale of Fotolia to Adobe in December 2014, the €80m sale of Trovit
to Next Co. in October 2014, the sale of Facile.it to Oakley Capital in
September 2014, the $230m sale of Yad2 to Axel Springer in May 2014 and
the sale of a 30% stake in Softonic to Partners Group in February 2013.

About NOAH Conference: NOAH is Europe’s premier growth conference
for leaders in the European digital ecosystem. The highly curated NOAH
events are significant for their unparalleled networking experience.
NOAH attendees mainly include senior executives (70%) and world class
investors (20%). On stage, industry leaders present their businesses and
how they are changing their industries. NOAH has hosted over 70 digital
unicorns on stage in recent years, more than any other conference. Each
event also features a selection of Europe’s most promising start-ups.
Since 2009, NOAH has hosted 15 conferences in Berlin, London and Tel
Aviv. In 2018, Over 6,000 attendees attended NOAH Conferences in Tel
Aviv, Berlin and London.

Marking NOAH’s 10th year, its flagship Berlin conference is
moving to a new venue, STATION-Berlin, to accommodate the growing event.
It will feature 400 speakers segmented across 10 major
verticals; FinTech & InsurTech, Ecommerce, Marketplace & Classifieds,
B2B Saas, Mobility & Travel of the Future, Industrial Digitization,
Digital Health, Revolutionary Consumer Products, EduTech, Cognitive
Computing and Blockchain-Powered Businesses. A Launchpad Stage
will feature elevator pitches by over 80 of the most promising,
hand-picked startups. Beginning in 2020, NOAH will be adding a Zurich
conference, an invite-only event designed to connect international
investors and family offices with Swiss startups and global success
stories and featuring a mainstage speaker lineup consisting exclusively
of corporate and startup CEOs. A selection of Swiss, European and
Israeli startups with near-term capital needs will be matched with
high-level corporates and investors from Family Offices and funds. For
more information, please refer to:
http://static.noah-conference.com/media/presentations/NOAH-Conference-Overview.pdf

For Press Materials: https://blog.ourcrowd.com/noahadvisors/

Contacts

OurCrowd press contact: Leah Stern, OurCrowd Dir. Of
Communications / UK: +44 747-0196826 / E: [email protected]
NOAH
press contact:
Maike Schöffel, Account Manager at Piabo / DE: +49 30
25762050 / E: [email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect

Published

on

Continue Reading

Cannabis

Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand

Published

on

Continue Reading

transfer

IMC to transfer its Oranim Pharmacy shares back to the seller

Published

on

imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller

TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the  seller.

“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to,  the occurrence of growth opportunities and the likelihood of growth potential.

Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contacts:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania